Geno Germano
President and General Manager, Specialty Care Business Unit

President and General Manager Geno Germano leads Pfizer's Specialty Care Business Unit, which works closely with specialty physicians and stakeholders to provide medicines to help treat a variety of serious and life-threatening conditions. With the combined portfolios and resources of Wyeth and Pfizer, Specialty Care has grown substantially. The business unit's current portfolio includes more than 20 medicines in 12 disease areas, and the pipeline contains more than 25 compounds and indications in Phases II and III. Specialty Care holds leadership positions in vaccines and disease areas such as inflammation, infectious disease, hemophilia and ophthalmology.

Specialty Care is present in global markets, including North America, Europe and Asia. Its medicines are trusted by leading physicians, and relied upon by people at every stage of life - from young children who receive vaccines against pneumococcal disease to adults who depend upon biologic treatment for rheumatoid arthritis.

Geno joined Pfizer from Wyeth, where he was President, U.S. and Pharmaceutical Business Units for Wyeth Pharmaceuticals, responsible for its $10 billion annual business across Pharmaceuticals, Biologics and Vaccines. In addition, he led Global Strategy for the Pharmaceutical and Institutional business units for major products in Neuroscience, Gastroenterology, Women's Health, Infectious Diseases and Immunology.

In his 25 years in the pharmaceutical industry, Geno has held diverse positions, including Executive Vice President and General Manager for Wyeth Global Vaccines; Managing Director, Wyeth Australia and New Zealand; and Executive Vice President and General Manager of the Pharmaceutical Business Unit. He led numerous key product launches in primary and specialty care.

Geno serves on the Advisory Board of the Healthcare Business Women's Association. and is a Trustee of the Albany College of Pharmacy, where he received his Bachelor of Science degree in Pharmacy in 1983.